Therapeutic Apheresis Market to Reach $2.8 Billion, Globally, by 2035 at 6.7% CAGR: Allied Market Research

The growth of the therapeutic apheresis market is driven by rise in prevalence of chronic and autoimmune diseases, technological advancements in apheresis devices, and favorable government initiatives and reimbursement policies.

WILMINGTON, Delaware, March 18, 2025 /PRNewswire/ -- Allied Market Research published a report, titled, "Therapeutic Apheresis Market by Product Type (Devices, Consumables, and Software), Procedure Type (Therapeutic plasma exchange (TPE), Photopheresis, Low Density Lipid Removal, Stem Cell Harvest, and Other Procedures), Application (Hematology, Neurology, Oncology, and Others), and End User (Hospitals, Blood Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2035". According to the report, the "therapeutic apheresis market" was valued at $1.3 billion in 2023, and is estimated to reach $2.8 billion by 2035, growing at a CAGR of 6.7% from 2024 to 2035.

Request Sample of the Report on Global Therapeutic Apheresis Market 2035 - https://www.alliedmarketresearch.com/request-sample/A281407

Prime determinants of growth  

The growth of the therapeutic apheresis market is driven by rise in prevalence of chronic and autoimmune diseases, technological advancements in apheresis devices, and favorable government initiatives and reimbursement policies. However, high cost of apheresis procedures and lack of skilled professionals and limited awareness are significant restraining factors for the growth of the therapeutic apheresis market. On the other hand, high growth potential in emerging countries provides lucrative opportunities for the market growth.

Report coverage & details 

Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A281407

The consumables segment held the largest market share in 2023

By product type, the consumables segment held the largest market share in 2023, accounting for more than two-thirds of the therapeutic apheresis market. This is attributed to high demand for disposable apheresis kits, anticoagulants, and filters, which are essential for each procedure. The recurring need for consumables in every treatment session drives the segment growth. 

The therapeutic plasma exchange (TPE) segment held the largest market share in 2023

By procedure type, the therapeutic plasma exchange (TPE) segment held the largest market share in 2023, accounting for more than half the therapeutic apheresis market owing to its widespread use in treating neurological, hematological, and autoimmune disorders. The high efficacy of TPE in rapidly removing harmful antibodies and toxins from the bloodstream drives its adoption.

The hematology segment held the largest market share in 2023

By application, the hematology segment held the largest market share in 2023, accounting for more than three-fifths of the therapeutic apheresis market. The same segment is expected to register the highest CAGR during the forecast period. This is attributed to rise in prevalence of hematological disorders such as sickle cell disease, thrombotic thrombocytopenic purpura (TTP), and leukemia, which require apheresis-based treatments. 

The hospitals segment held the largest market share in 2023

By end user, the hospitals segment held the largest market share in 2023, accounting for around three-fifths of the therapeutic apheresis market, owing to the high patient inflow for apheresis procedures in hospital settings, driven by availability of advanced medical infrastructure and specialized healthcare professionals.

North America held the largest market share in 2023

Region-wise, North America held the largest market share in 2023, accounting for more than two-fifths of the therapeutic apheresis market due to rise in prevalence of hematological and autoimmune disorders, well-established healthcare infrastructure, and strong reimbursement policies. However, Asia-Pacific is expected to witness the fastest CAGR of 7.8% from 2024 to 2035 owing to the rise in prevalence of hematological and autoimmune disorders, increasing healthcare expenditures, and growing awareness about therapeutic apheresis.

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A281407

Leading Market Players

• Asahi Kasei Corporation
• Terumo Corporation
• Kaneka Corporation
• Miltenyi Biotech
• B. Braun SE
• Baxter International Inc.
• Medica SPA
• Haemonetics Corporation
• Becton, Dickinson and Company
• Fresenius SE And Co. KGaA

The report provides a detailed analysis of these key players in the therapeutic apheresis market. These players have adopted strategies such as product launch, agreement, collaboration, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to highlight the competitive scenario.

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

SOURCE Allied Market Research